Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IsoTis launches CellActive burn wound product:

This article was originally published in Clinica

Executive Summary

Dutch company IsoTis is launching its first biological product, CellActive skin. The product, which is intended for the treatment of severe burns, consists of keratinocyte sheets cultured from the patient's own cells. Initially, the product will be available to 12 hospitals in Germany, Switzerland and Austria. CellActive is indicated for patients with burns to over 60-70% of the body surface. The Bilthoven company says that there are around 150 patients each year with this degree of burns to the body.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073988

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel